Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical and laboratory characteristics of Achromobacter xylosoxidans infection.

Literature DB >> 7358838

Clinical and laboratory characteristics of Achromobacter xylosoxidans infection.

Abstract

Achromobacter xylosoxidans was isolated from six patients. The organism causes opportunistic infections in patients who are compromised. A. xylosoxidans is a catalase- and oxidase-positive, motile, gram-negative rod that oxidizes xylose and glucose. The organism exists in a water environment and may be confused with Pseudomonas species. Unlike pseudomonas, achromobacter has peritrichous flagella. The clinical and laboratory characteristics of A. xylosoxidans are presented.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1980 PMID： 7358838 PMCID： PMC273340 DOI： 10.1128/jcm.11.2.141-145.1980

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

9 in total

1. Organisms resembling Alcaligenes faecalis.

Authors: H B MOORE; M J PICKETT
Journal: Can J Microbiol Date: 1960-02 Impact factor: 2.419

2. Staining, shape and arrangement of bacterial flagella.

Authors: E LEIFSON
Journal: J Bacteriol Date: 1951-10 Impact factor: 3.490

3. Strains of Achromobacter xylosoxidans from clinical material.

Authors: B Holmes; J J Snell; S P Lapage
Journal: J Clin Pathol Date: 1977-07 Impact factor: 3.411

4. Comparative D-gluconate metabolism and DNA base composition in Achromobacter and Alcaligenes.

Authors: J De Ley; K Kersters; J Khan-Matsubara; J M Shewan
Journal: Antonie Van Leeuwenhoek Date: 1970 Impact factor: 2.271

5. Achromobacter xylosoxidans n. sp. from human ear discharge.

Authors: E Yabuuchi; A Oyama
Journal: Jpn J Microbiol Date: 1971-09

6. Achromobacter xylosoxidans isolates in Hawaii.

Authors: F D Pien; H Y Higa
Journal: J Clin Microbiol Date: 1978-02 Impact factor: 5.948

7. [Clinical and bacteriological studies on infections due to Achromobacter xylosoxidans (author's transl)].

Authors: J Igari; N Kosakai; T Oguri; H Kakegawa
Journal: Jpn J Antibiot Date: 1978-04

8. Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency.

Authors: D L Dworzack; C M Murray; G R Hodges; W G Barnes
Journal: Am J Clin Pathol Date: 1978-10 Impact factor: 2.493

9. Cerebral ventriculitis associated with Achromobacter xylosoxidans.

Authors: S Shigeta; Y Yasunaga; K Honzumi; H Okamura; R Kumata; S Endo
Journal: J Clin Pathol Date: 1978-02 Impact factor: 3.411

9 in total

35 in total

1. Continuous ambulatory peritoneal dialysis-related exit-site infections caused by Achromobacter denitrificans and A. xylosoxidans.

Authors: M T Tsai; W C Yang; C C Lin
Journal: Perit Dial Int Date: 2012 May-Jun Impact factor: 1.756

2. Antibody response to Achromobacter xylosoxidans during HIV infection is associated with lower CD4 levels and increased lymphocyte activation.

Authors: Erick T Tatro; Intan Purnajo; Douglas D Richman; Davey M Smith; Sara Gianella
Journal: Clin Vaccine Immunol Date: 2013-10-30

3. Meningitis caused by Alcaligenes (Achromobacter) xylosoxidans associated with epidural catheter.

Authors: J M Ramos; R Fernández-Roblas; P García-Ruiz; F Soriano
Journal: Infection Date: 1995 Nov-Dec Impact factor: 3.553

4. Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors: B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal: J Clin Microbiol Date: 2017-04-26 Impact factor: 5.948